Core Viewpoint - Ark Health Holdings Limited announced the resignation of Mr. Xie Fangmin as Chairman, CEO, and authorized representative effective December 7, 2025, to focus on personal matters, while he will continue to provide guidance as a non-executive director [1][2] Group 1: Leadership Changes - Mr. David McKee Hand has been appointed as the new Chairman effective December 7, 2025, following Mr. Xie Fangmin's resignation [1] - The board has initiated a formal search for a new CEO, considering both internal and external candidates to ensure a suitable successor [1] Group 2: Contributions and Future Direction - Mr. Xie Fangmin has been instrumental in the company's long-term development since its founding in 2015, introducing the "H2H (Hospital to Home)" model and integrating AI with healthcare [2] - Under his leadership, the company transitioned from a pharmaceutical e-commerce platform to a leading "AI + chronic disease management" enterprise, successfully listing on the Hong Kong Stock Exchange in 2024 [2] - The company aims to continue focusing on online chronic disease management, leveraging AI to serve millions of patients and contribute to the "Healthy China 2030" initiative [2]
方舟云康发布公告：David McKee HAND获委任为主席 “AI+慢病管理”战略笃定前行